Terms: = Liver cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK
233 results:
1. Predisposing deleterious variants in the cancer-associated human kinases in the global populations.
Khan SA; Anwar M; Gohar A; Roosan MR; Hoessli DC; Khatoon A; Shakeel M
PLoS One; 2024; 19(4):e0298747. PubMed ID: 38635549
[TBL] [Abstract] [Full Text] [Related]
2. liver transplantation for advanced-stage primary hepatic yolk sac tumor: A case report and literature review.
Liu GH; Qiu MK; Wang Y; Zhang TT; Wang LJ; Guan WB; Ou JM; Chen LT
Medicine (Baltimore); 2023 Dec; 102(50):e35821. PubMed ID: 38115376
[TBL] [Abstract] [Full Text] [Related]
3. Discovery of novel 3-(1H-pyrazol-4-yl)-1H-indazole derivatives as potent type II trk inhibitors against acquired resistance.
Qin Q; Guo Z; Lu S; Wang X; Fu Q; Wu T; Sun Y; Liu N; Zhang H; Zhao D; Cheng M
Eur J Med Chem; 2024 Jan; 264():115953. PubMed ID: 38029466
[TBL] [Abstract] [Full Text] [Related]
4. Increasing risk of hepatocellular carcinoma with successive generations in the United States among Mexican American adults: The Multiethnic Cohort.
Acuna N; Zhou K; Pinheiro PS; Cheng I; Shariff-Marco S; Lim T; Wilkens LR; Le Marchand L; Haiman CA; Setiawan VW
Cancer; 2024 Jan; 130(2):267-275. PubMed ID: 37982329
[TBL] [Abstract] [Full Text] [Related]
5. A novel c-Met/trk inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation.
An B; Nie W; Hu J; Fan Y; Nie H; Wang M; Zhao Y; Yao H; Ren Y; Zhang C; Wei M; Li W; Liu J; Yang C; Zhang Y; Li X; Tian G
Cell Death Dis; 2023 Nov; 14(11):728. PubMed ID: 37945598
[TBL] [Abstract] [Full Text] [Related]
6. Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [
Günther T; Holzleitner N; Viering O; Beck R; Wienand G; Dierks A; Pfob CH; Bundschuh RA; Kircher M; Lapa C; Wester HJ
J Nucl Med; 2024 Jan; 65(1):33-39. PubMed ID: 37945383
[TBL] [Abstract] [Full Text] [Related]
7. Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.
Němčíková P; Brunerová L
Vnitr Lek; 2023; 69(5):312-315. PubMed ID: 37827829
[TBL] [Abstract] [Full Text] [Related]
8. Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review.
Li P; Zhang Y; Xu T; Zhu J; Wei T; Zhao W
Nucl Med Commun; 2023 Dec; 44(12):1114-1125. PubMed ID: 37769014
[TBL] [Abstract] [Full Text] [Related]
9. Immunosuppressive CD10
Meng Y; Ye F; Nie P; Zhao Q; An L; Wang W; Qu S; Shen Z; Cao Z; Zhang X; Jiao S; Wu D; Zhou Z; Wei L
J Hepatol; 2023 Dec; 79(6):1435-1449. PubMed ID: 37689322
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
[TBL] [Abstract] [Full Text] [Related]
11. Expression and prognostic impact of NTF3 and trkC in hepatocellular carcinoma.
Wang H; Zhong C; Qi L; Fang X; Yuan Y
Scand J Gastroenterol; 2023; 58(11):1309-1316. PubMed ID: 37272057
[TBL] [Abstract] [Full Text] [Related]
12. Head-to-Head Comparison of [
Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
[No Abstract] [Full Text] [Related]
13. Elaboration of Ntrk-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
Wu S; Liu Y; Shi X; Zhou W; Zeng X
Dig Liver Dis; 2023 Dec; 55(12):1757-1764. PubMed ID: 37142453
[TBL] [Abstract] [Full Text] [Related]
14. Thirty synchronous medullary and papillary thyroid carcinomas.
Zhang D; Yang M; Zhang X; Wang C; Li K; Wang H; Chi H; Sui C; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1153248. PubMed ID: 37065753
[TBL] [Abstract] [Full Text] [Related]
15. Design, synthesis and biological evaluation of novel indolin-2-one derivatives as potent second-generation trks inhibitors.
Qin Q; Fu Q; Wang X; Lv R; Lu S; Guo Z; Wu T; Sun Y; Sun Y; Liu N; Zhao D; Cheng M
Eur J Med Chem; 2023 May; 253():115291. PubMed ID: 37030091
[TBL] [Abstract] [Full Text] [Related]
16. A Two-Step Diagnostic Approach for Ntrk Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas.
Demols A; Rocq L; Perez-Casanova L; Charry M; De Nève N; Ramadhan A; Van Campenhout C; De Clercq S; Maris C; Closset J; Lucidi V; Salmon I; D'Haene N
Oncologist; 2023 Jul; 28(7):e520-e525. PubMed ID: 36994874
[TBL] [Abstract] [Full Text] [Related]
17. Primary inflammatory myofibroblastic tumour of the liver: a clinicopathological and genetic study including a subset with ETV6::Ntrk3 fusion.
Han Q; Zhang Z; He X; Chen M; Pang X; Chen C; Du T; Zhang H
Histopathology; 2023 May; 82(6):925-936. PubMed ID: 36748182
[TBL] [Abstract] [Full Text] [Related]
18. Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the
von Guggenberg E; Uprimny C; Klinger M; Warwitz B; Sviridenko A; Bayerschmidt S; di Santo G; Virgolini IJ
J Nucl Med; 2023 Jun; 64(6):859-862. PubMed ID: 36657979
[TBL] [Abstract] [Full Text] [Related]
19. Biphenotypic Immunohistochemical Features and ntrk1 Amplification in Intermediate Cell Carcinoma of the liver.
Radhakrishnan S; Martin CA; Vij M; Raju LP; Gowripriya G; Jana K; Rammohan A; Jothimani D; Kaliamoorthy I; Veldore VH; Rela M
Int J Surg Pathol; 2023 Aug; 31(5):839-845. PubMed ID: 36476133
[TBL] [Abstract] [Full Text] [Related]
20. Tropomyosin receptor kinase protein expression in Thai cholangiocarcinoma: Clinicopathological correlation, expression pattern, and prognosis.
Leepisuth P; Watcharadetwittaya S; Sa-Ngiamwibool P
Ann Diagn Pathol; 2022 Oct; 60():151996. PubMed ID: 35753289
[TBL] [Abstract] [Full Text] [Related]
[Next]